Notes to the Financial Statements
continued
Notes
41 Post Balance Sheet events
Non adjusting events
Following the end of the financial year, the Uniphar Group has made the following investment transactions:
• In January 2017, Trennamally Limited, a Uniphar plc wholly owned company, acquired a tranche of pharmacies from Riverchem
DAC for a consideration of €2.7 million.
• In April 2017, Uniphar plc acquired OUTiCO Limited. OUTiCO provides outsourcing data intelligence and consultancy to companies
in the UK. The cost of this acquisition inclusive of deferred consideration will amount to a maximum of €5.9 million.
• In April 2017, Lindchem DAC sold a further two Allcare pharmacies for a total consideration of €1.5 million.
The investment acquisitions will be accounted for in the 2017 financial statements.
42 Approval of financial statements
The directors approved the financial statements on 25 May 2017.
98 | Annual Report 2016
Annual Report 2016 | 99